A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression
✍ Scribed by Alessandro Serretti; Alberto Chiesa; Raffaella Calati; Isabelle Massat; Sylvie Linotte; Siegfried Kasper; Yves Lecrubier; Irina Antonijevic; Carlos Forray; Lenore Snyder; Joseph Bollen; Joseph Zohar; Diana De Ronchi; Daniel Souery; Julien Mendlewicz
- Book ID
- 113667330
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 270 KB
- Volume
- 128
- Category
- Article
- ISSN
- 0165-0327
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Major depression is characterized by overactivity of the hypothalamic±pituitary±adrenal (HPA) axis. Dexamethasone (DEX), the glucocorticoid agonist, has been shown to be eective in the treatment of depression. We chose to examine the impact of a short course of DEX treatment on depressive symptomato
Eight patients suering from major depression were treated with trazodone 150 or 200 mg bid (non-responders) over 5 weeks, preceded and followed by a placebo week. Cognitive functioning was tested in the morning at the end of each treatment week. Before trazodone treatment commenced, patients' cognit
## Abstract A previously published model‐free linkage analysis of chromosome 2q33–35, highlighted by previous case–control studies and supported by within‐family analyses employing the transmission disequilibrium test, revealed evidence of sex‐specific linkage of the __CREB1__‐containing region of